News
Entrepreneurship raises your risk of obesity, but small changes to your diet can have similar affects to new weight-loss ...
RELATED: Ozempic and Mounjaro Patients Report Potentially Fatal New Side Effect. In speaking with The Cut, Jodi LoGerfo, DNP, a nurse practitioner and hair-loss specialist, points to telogen effluvium ...
Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
Aggressive social media marketing by influencers has fuelled a surge in over-the-counter use of the diabetes and obesity ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
The Fed kept rates steady, as most economists had expected, but struck a more hawkish tone, causing a mid-afternoon stock sell-off.
Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, ...
Watch a subscriber-only conversation on if algorithms can ever be fair.
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...
16h
Benzinga on MSNNovo Nordisk Cuts 2025 Forecasts Again, Shares Drop 17% Amid Wegovy Concerns
Novo Nordisk shares dropped as much as 17% Tuesday after the obesity drugmaker cut its full-year sales and profit outlook for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results